Healthy volunteers to test diabetes pill with and without food

NCT ID NCT07396844

Not yet recruiting Knowledge-focused Sponsor: LG Chem Source: ClinicalTrials.gov ↗

First seen Feb 16, 2026 · Last updated Jun 12, 2026 · Updated 17 times

Summary

This study looks at how taking a new combination diabetes pill (gemigliptin, dapagliflozin, and metformin) with or without food changes the way the body absorbs the medicine. About 28 healthy adults in Thailand will take a single dose under both conditions. The results will help doctors understand whether to take this pill with meals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Siriraj Hospital

    Nakhon Pathom, 73170, Thailand

    Contact

Conditions

Explore the condition pages connected to this study.